These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 12889553)
1. Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Lanas A; Rodrigo L; Márquez JL; Bajador E; Pérez-Roldan F; Cabrol J; Quintero E; Montoro M; Gomollón F; Santolaria S; Lorente S; Cucala M; Nuevo J; Scand J Gastroenterol; 2003 Jul; 38(7):693-700. PubMed ID: 12889553 [TBL] [Abstract][Full Text] [Related]
2. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623 [TBL] [Abstract][Full Text] [Related]
3. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802 [TBL] [Abstract][Full Text] [Related]
4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL; Huang B; Amer F; Christopoulos NG Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480 [TBL] [Abstract][Full Text] [Related]
5. Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding. Lanas A; Ferrández A Expert Opin Drug Saf; 2002 Sep; 1(3):245-52. PubMed ID: 12904140 [TBL] [Abstract][Full Text] [Related]
6. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. Lanas AI Am J Med; 2001 Jan; 110(1A):70S-73S. PubMed ID: 11166003 [TBL] [Abstract][Full Text] [Related]
7. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. Iwamoto J; Saito Y; Honda A; Matsuzaki Y World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156 [TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111 [TBL] [Abstract][Full Text] [Related]
11. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for gastrointestinal bleeding associated with low-dose aspirin. Valkhoff VE; Sturkenboom MC; Kuipers EJ Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151 [TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [TBL] [Abstract][Full Text] [Related]
14. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849 [TBL] [Abstract][Full Text] [Related]
15. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563 [TBL] [Abstract][Full Text] [Related]
16. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
17. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden. Brusselaers N; Lagergren J BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219 [TBL] [Abstract][Full Text] [Related]
18. Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly. Lanas A; Ferrandez A Drugs Aging; 2007; 24(2):121-31. PubMed ID: 17313200 [TBL] [Abstract][Full Text] [Related]
19. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan. Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677 [TBL] [Abstract][Full Text] [Related]
20. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]